Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder

References

• Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann- einecke U, Rüther E, et al. 2007. Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. Eur Neuropsychopharmacol 17:417–429.
   PubMed Web of Science ®Google Scholar
• Ahmad O, Wardlaw J, Whiteley WN. 2012. Correlation of levels of neuronal and glial markers with radiological measures of infarct volume in ischaemic stroke: a systematic review. Cerebrovasc Dis 33:47–54.
   PubMed Web of Science ®Google Scholar
• Akhisaroglu M, Manev R, Akhisaroglu E, Uz T, Manev H. 2003. Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus. NeuroReport 14:1471–1473.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Ghosh AK, Ghosh B, Bhattacharyya S, Mondal AC. 2013. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the hippocampus from suicide: An analysis in human postmortem brain. Clin Med Insights Pathol 6:1–11.
   PubMedGoogle Scholar
• Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, et al. 2011. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68:1624–1630.
   PubMed Web of Science ®Google Scholar
• Casmiro M, Maitan S, de Pasquale F, Cova V, Scarpa E, Vignatelli L; NSE Study Group. 2005. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur J Neurol 12:369–374.
   PubMed Web of Science ®Google Scholar
• Cohen, J. 1988. Statistical power analysis for the behavioral ciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
   Google Scholar
• Cooper EH. 1999. Neuron-specific enolase. Int J Biol Markers 9:205–210.
   Google Scholar
• Duan P, Zhang Y, Han X, Liu J, Yan W, Xing Y. 2012. Effect of neuronal induction on NSE, Tau, and Oct4 promoter methylation in bone marrow mesenchymal stem cells. In Vitro Cell Dev Biol Anim 48:251–258.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. 1997. Structured Clinical Interview for DSM-IV Axis I disorders (SCID I). New York: Biometric Research Department.
   Google Scholar
• Frodl T, Möller H-J, Meisenzahl E. 2008. Neuroimaging genetics: new perspectives in research on major depression? Acta Psychiatr Scand 118:363–372.
   PubMed Web of Science ®Google Scholar
• Fujiya A, Nagasaki H, Seino Y, Okawa T, Kato J, Fukami A, et al. 2014. The role of S100B in the interaction between adipocytes and macrophages. Obesity 22:371–379.
   PubMed Web of Science ®Google Scholar
• Gonçalves CA, Leite MC, Guerra MC. 2010. Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc Psychiatry Neurol 2010:790431.
   Google Scholar
• Grabe HJ, Ahrens N, Rose HJ, Kessler C, Freyberger HJ. 2001. Neurotrophic factor S100 beta in major depression. Neuropsychobiology 44:88–90.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
   PubMed Web of Science ®Google Scholar
• Hattori T, Takei N, Mizuno Y, Kato K, Kohsaka S. 1995. Neurotrophic and neuroprotective effects of neuron-specific enolase on cultured neurons from embryonic rat brain. Neurosci Res 21:191–198.
   PubMed Web of Science ®Google Scholar
• Hein née Maier K, Köhler A, Diem R, Sättler MB, Demmer I, Lange P, et al. 2008. Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis. Neurosci Lett 436:72–76.
   PubMed Web of Science ®Google Scholar
• Jakobsson J, Bjerke M, Ekman CJ, Sellgren C, Johansson AG, Zetterberg H, et al. 2014. Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of Bipolar Disorder patients. Neuropsychopharmacology 39: 2349–2356.
   PubMed Web of Science ®Google Scholar
• Jang BS, Kim H, Lim SW, Jang KW, Kim DK. 2008. Serum S100B levels and major depressive disorder: Its characteristics and role in antidepressant response. Psychiatry Invest 5:193–198.
   PubMed Web of Science ®Google Scholar
• Kaiser E, Kuzmits R, Pregant P, Burghuber O, Worofka W. 1989. Clinical biochemistry of neuron specific enolase. Clin Chim Acta 183:13–31.
   PubMed Web of Science ®Google Scholar
• Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. 2003. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer 97:2806–2813.
   PubMed Web of Science ®Google Scholar
• Kern N, Sheldrick AJ, Schmidt FM, Minkwitz J. 2012. Neurobiology of depression and novel antidepressant drug targets. Curr Pharm Des 18:5791–5801.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. 2005. Lifetime prevalence and age of onset distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602.
   PubMed Web of Science ®Google Scholar
• Kuhn M, Popovic A, Pezawas L. 2014. Neuroplasticity and memory formation in major depressive disorder: An imaging genetics perspective on serotonin and BDNF. Restor Neurol Neurosci 32:25–49.
   PubMed Web of Science ®Google Scholar
• Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H. 2013. Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 25:592–603.
   PubMed Web of Science ®Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva Vargas R, et al. 2007. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett 421:33–36.
   PubMed Web of Science ®Google Scholar
• Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, et al. 2012. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 20:644–659.
   Google Scholar
• Nygaard O, Langbakk B, Romner B. 1998. Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scand J Clin Lab Invest 58:183–186.
   PubMed Web of Science ®Google Scholar
• Parker TG, Marks A, Tsoporis JN. 1998. Induction of S100b in myocardium: an intrinsic inhibitor of cardiac hypertrophy. Can J Appl Physiol 23:377–389.
   PubMedGoogle Scholar
• Pollak D, CairnS N, Lubec G. 2003. Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer’s disease and Pick’s disease. J Neural Transm (Suppl) 67:149–158.
   Google Scholar
• Rajkowska G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766–777.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Stockmeier CA. 2013. Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. Curr Drug Targets 14:1225–1236.
   PubMed Web of Science ®Google Scholar
• Rong H, Wang G, Liu T, Wang H, Wan Q, Weng S 2010. Chronic mild stress induces fluoxetine-reversible decreases in hippocampal and cerebrospinal fluid levels of the neurotrophic factor S100B and its specific receptor. Int J Mol Sci 11: 5310–5322.
   PubMed Web of Science ®Google Scholar
• Sacher J, Neumann J, Fünfstück T, Soliman A, Villringer A, Schroeter ML. 2012. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord 140:142–148.
   PubMed Web of Science ®Google Scholar
• Savitz JB, Rauch SL, Drevets WC. 2013. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry 18:528–539.
   PubMed Web of Science ®Google Scholar
• Schindler S, Geyer S, Strauß M, Anwander A, Hegerl U, Turner R, et al. 2012. Structural studies of the hypothalamus and its nuclei in mood disorders. Psychiatry Res 201:1–9.
   PubMed Web of Science ®Google Scholar
• Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, et al. 2014. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res 55:29–34.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE. 2008. Serum markers support disease-specific glial pathology in major depression. J Affect Disord 111: 271–280.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Steiner J, Mueller K. 2011. Glial pathology is modified by age in mood disorders – a systematic meta- analysis of serum S100B in vivo studies. J Affect Disord 134:32–38.
   PubMed Web of Science ®Google Scholar
• Sen J, Belli A. 2007. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res. 85:1373–1380.
   PubMed Web of Science ®Google Scholar
• Shapiro LA, Bialowas-McGoey LA, Whitaker-Azmitia PM. 2010. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer’s disease: Studies in an S100B overexpressing mouse model. Cardiovasc Psychiatry Neurol 2010:153657.
   PubMedGoogle Scholar
• Song YJ, Korgaonkar MS, Armstrong LV, Eagles S, Williams LM, Grieve SM. 2014. Tractography of the brainstem in major depressive disorder using diffusion tensor imaging. PLoS One 9:e84825.
   Web of Science ®Google Scholar
• Steiner J, Bernstein HG, Bielau H, Berndt A, Brisch R, Mawrin C, et al. 2007. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 8:2.
   PubMed Web of Science ®Google Scholar
• Steiner J, Myint AM, Schiltz K, Westphal S, Bernstein HG, Walter M, et al. 2010. S100B Serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovasc Psychiatry Neurol 2010:480707.
   Google Scholar
• Streitbürger DP, Arelin K, Kratzsch J, Thiery J, Steiner J, Villringer A, et al. 2012. Validating serum S100B and Neuron-Specific Enolase as biomarkers for the human brain – A combined serum, gene expression and MRI study. PLoS One 7:e43284.
   PubMed Web of Science ®Google Scholar
• Takei N, Kondo J, Nagaike K, Ohsawa K, Kato K, Kohsaka S. 1991. Neuronal survival factor from bovine brain is identical to neuron-specific enolase. J Neurochem 57: 1178–11184.
   PubMed Web of Science ®Google Scholar
• Tramontina AC, Tramontina F, Bobermin LD, Zanotto C, Souza DF, Leite MC, et al. 2008. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry. 32(6):1580–1583.
   PubMed Web of Science ®Google Scholar
• Uher T, Bob P. 2012. Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders. Neurosci Lett 529:139–143.
   PubMed Web of Science ®Google Scholar
• Wiener CD, Jansen K, Ghisleni G, Kaster MP, Souza LD, Lara DR, et al. 2013. Reduced serum levels of neuron specific enolase (NSE) in drug-naïve subjects with major depression and bipolar disorder. Neurochem Res 38:1394–1398.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) web site. Depression. http://www.who.int/mental_health/management/depression/en/ (accessed January 2014).
   Google Scholar
• Wulsin LR, Vaillant GE, Wells VE. 1999. A systematic review of the mortality of depression. Psychosom Med 61:6–17.
   PubMed Web of Science ®Google Scholar
• Yang K, Xie GR, Hu YQ, Mao FQ, Su LY. 2008. The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression. J Neural Transm 115:1687–1694.
   PubMed Web of Science ®Google Scholar
• Youden WJ. 1950. Index for rating diagnostic tests. Cancer 3:32–35.
   PubMed Web of Science ®Google Scholar
• Yuan P, Zhou R, Wang Y, Li X, Li J, Chen G, Guitart X, Manji HK. 2010. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia. J Affect Disord 124:164–169.
   PubMed Web of Science ®Google Scholar